REVISED FOOD AND DRUG ADMINISTRATION RISK CATEGORIES OF DRUGS DURING PREGNANCY

Ajitha Sharma; Rathnakar Up

doi:10.22159/ajpcr.2017.v10i7.16539

Authors

Ajitha Sharma Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangalore, Karnataka, India.
Rathnakar Up Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangalore, Karnataka, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i7.16539

Keywords:

Pharmacology

Abstract

A comment on the revised FDA categories for drugs during pregnancy.

Downloads

Download data is not yet available.

Author Biographies

Ajitha Sharma, Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangalore, Karnataka, India.

Dr. Ajitha Sharma, Assistant Professor, Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangalore â€“ 575018, Karnataka, India.

Rathnakar Up, Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangalore, Karnataka, India.

Dr. Rathnakar U. P., Professor and Head, Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangalore â€“ 575018, Karnataka, India.

References

FDA Pregnancy Categories. FDA Pregnancy Risk Information: An Update. Available from: https://www.drugs.com/pregnancy-categories. html. [Last accessed on 2016 Nov 30].

Law R, Bozzo P, Koren G, Einarson A. FDA pregnancy risk categories and the CPS: Do they help or are they a hindrance? Can Fam Physician 2010;56(3):239-41.

Priya PP, Rajesh K, Reddy KP, Devi VR. Pattern of drug use in pregnant women and evaluating the effect of supplements on growth of fetus. Int J Pharm Pharm Sci 2013;5(4):651-4.

Agarwal M, Nayeem M, Safhi MM, Makeen HA, Sumaily JM, Gupta N. Prescribing pattern of drugs in the department of obstetrics and gynaecology in expecting mothers in Jazan region, KSA. Int J Pharm Pharm Sci 2014;6(1):658-61.

Mosley JF 2nd, Smith LL, Dezan MD. An overview of upcoming changes in pregnancy and lactation labeling information. Pharm Pract (Granada) 2015;13(2):605.

Pregnancy and Lactation Labeling (Drugs) Final Rule. December 3; 2014. Available from: http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/Labeling/ ucm093307.htm. [Last accessed on 2016 Nov 30].

FDA News Release. FDA Issues Final Rule on Changes to Pregnancy and Lactation Labeling Information for Prescription Drug and Biological Products. December 3; 2014. Available from: http://www. fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317. htm. [Last accessed on 2016 Nov 30].

Lim L, Thompson K. New prescription drug labeling for pregnant or nursing women. Pharm Today 2016;22:40-1.